Combination chemo-radiation therapy may help preserve larynx for patients with laryngeal cancer

(The JAMA Network Journals) In a study published online by JAMA Otolaryngology-Head &Neck Surgery, James A. Bonner, M.D., of the University of Alabama at Birmingham, and colleagues assessed the rates of laryngeal (having to do with the larynx [voice box]) preservation and laryngectomy-free survival in patients receiving the monoclonal antibody cetuximab and radiation therapy (CRT) or radiation therapy alone.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news

Related Links:

More News: Cancer | Cancer & Oncology | Erbitux | Laryngeal Cancer | Laryngectomy | Radiation Therapy | Study